Tag Archives: Mylan

Pfizer Japan drawn into valsartan recall after finding API from Mylan is tainted

The global recall of valsartan has now extended to Pfizer and to Japan, via Mylan and India. According to a translated copy of its announcement, Pfizer’s Tokyo-based Japanese subsidiary said it is recalling from the country five lots of its blood pressure combo drug Amubaro because its API contains impurities that are probable carcinogens. The recall began… Read More »

Mylan overhaul of West Virginia plant has a ways to go

While Mylan’s third quarter results impressed analysts, the generics drugmaker is still dealing with some significant manufacturing issues, some of them not of its own making. Its adjusted earnings per share beat analyst expectations to land at $ 1.25 during the quarter, representing a 14% year-over-year increase. “We see Mylan as one of the better-positioned… Read More »